Printer Friendly

Galileo Life Sciences Merges with Canadian Health Services Firm Novo Healthnet.

MANews-(C)2009-2016

12 May 2016 - US-based clinic operator and medical cannabis producer and Galileo Life Sciences, Inc.'s (OTC: MDRM) Canadian subsidiary has signed a merger agreement with Canadian health services provider Novo Healthnet Ltd., the company said.

Terms of the deal were not disclosed.

Novo is Canada's third largest provider of whole health services including physiotherapy, massage therapy, and chiropractic.

The company's primary line of health care interest is in providing rehabilitation medicine. Novo and its affiliates have a chain of 114 clinics that are staffed and administered by licensed health care professionals.

Novo Healthnet also has a binding business partnership with a licensed producer and distributor of medical cannabis and its derivatives coupled with marketing and distribution rights to an on-line virtual physician access system.

This merger will give the 100,000 patients who visit the health clinics located across Canada, on-site access to the licensed producers.

Galileo Life Sciences is a company strategically focused on the production and distribution of premium medical cannabis in North America.

Country: Canada

Sector: Healthcare

Target: Novo Healthnet Ltd

Buyer: Galileo Life Sciences

Vendor:

Deal size in USD:

Type: Merger

Financing: Cash and Stock

Status: Closed

Buyer advisor: , ,

Comment: Terms of the deal were not disclosed

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Geographic Code:1CANA
Date:May 12, 2016
Words:205
Previous Article:Grubhub Closes Acquisition of California Restaurant Delivery Service LAbite.
Next Article:Essendant Calls Off Acquisition of Staples' Wholesale Business, as Staples/Office Depot Merger Terminated.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters